News from primevax immuno-oncology, inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Jan 22, 2019, 12:20 ET PrimeVax Immuno-Oncology Signs Exclusive Worldwide Dengue Virus License with US Army for Cancer Treatments

PrimeVax Immuno-Oncology, Inc. announced today that the company has just signed an exclusive, worldwide license with the US Army Medical Materials...

Jan 07, 2019, 12:00 ET PrimeVax Immuno-Oncology Receives IND Permission From FDA

PrimeVax Immuno-Oncology, Inc. announced today that the company has successfully received their Investigational New Drug (IND) Application permission ...

Feb 22, 2017, 10:00 ET PrimeVax Immuno-Oncology to Present at Biocom Global Life Science Partnering Conference

PrimeVax Immuno-Oncology, Inc. announced today its CEO, Tony Chen, will be presenting at the Annual Biocom Global Life Science Partnering Conference. ...

Journalists and Bloggers

The news you need, when you need it.

Join PR Newswire for Journalists to access all of the free services designated to make your job easier.

In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.

LEARN MORE

News from primevax immuno-oncology, inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Jan 22, 2019, 12:20 ET PrimeVax Immuno-Oncology Signs Exclusive Worldwide Dengue Virus License with US Army for Cancer Treatments

Jan 07, 2019, 12:00 ET PrimeVax Immuno-Oncology Receives IND Permission From FDA

Feb 22, 2017, 10:00 ET PrimeVax Immuno-Oncology to Present at Biocom Global Life Science Partnering Conference

Journalists and Bloggers

The news you need, when you need it.

Contact Cision

Products

About

My Services